Wellysis Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$12M
- Investors
-
15
Wellysis General Information
Description
Developer of a smart wearable device designed to offer cardiologists comprehensive and accurate diagnostic support. The company's device offers a live streaming electrocardiogram on a mobile device with AI-assisted analysis and interpretation and generates a report that analyzes the data and provides the results to the medical staff, enabling physicians to easily manage heart conditions for their patients.
Contact Information
Website
www.wellysis.comCorporate Office
- 8th Floor, 425 Teheran-ro
- Seoul, Gangnam-gu 06159
- South Korea
Corporate Office
- 8th Floor, 425 Teheran-ro
- Seoul, Gangnam-gu 06159
- South Korea
Wellysis Timeline
Wellysis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 19-Dec-2025 | $12M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 01-Oct-2024 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 30-May-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 30-Oct-2020 | Completed | Product In Beta Test | |||
| 3. Accelerator/Incubator | 17-Sep-2020 | Completed | Product In Beta Test | |||
| 2. Accelerator/Incubator | 01-Sep-2019 | $500K | $2M | Completed | Product In Beta Test | |
| 1. Seed Round | 01-May-2019 | $1.5M | $1.5M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Wellysis Comparisons
Industry
Financing
Details
Wellysis Competitors (7)
One of Wellysis’s 7 competitors is ATsens, a Private Equity-Backed company based in Seongnam-Si, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ATsens | Private Equity-Backed | Seongnam-Si, South Korea | ||||
| Cardioscan (Australia) | Private Equity-Backed | Camberwell, Australia | ||||
| Biobeat | Venture Capital-Backed | Petah Tikva, Israel | ||||
| iRhythm Holdings | Formerly VC-backed | San Francisco, CA | ||||
| VitalConnect | Formerly VC-backed | San Jose, CA |
Wellysis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Wellysis Patents
Wellysis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250014692-A1 | Method, system and computer program for managing biometric data through linkage between patch-type bio signal measuring device and smart watch | Pending | 04-Jul-2023 | ||
| EP-4458258-A1 | Bio-signal measurement device attachable to and detachable from various body-wearable/body-attachable products and control method thereof | Pending | 04-May-2023 | ||
| US-12733874-B2 | Bio-signal measurement device attachable to and detachable from various body-wearable/body-attachable products and control method thereof | Active | 04-May-2023 | ||
| US-20240366151-A1 | Bio-signal measurement device attachable to and detachable from various body-wearable/body-attachable products and control method thereof | Active | 04-May-2023 | ||
| US-D1057168-S1 | Attachable biosignal sensing device | Active | 05-Dec-2022 |
Wellysis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Wellysis Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kolon Investment | Venture Capital | Minority | ||
| Korea Investment Partners | Venture Capital | Minority | ||
| Kyobo Life Insurance | PE-Backed Company | Minority | ||
| Kyobo Securities | Corporation | Minority | ||
| Samsung Securities | Corporation | Minority |
Wellysis FAQs
-
When was Wellysis founded?
Wellysis was founded in 2019.
-
Where is Wellysis headquartered?
Wellysis is headquartered in Seoul, South Korea.
-
What is the size of Wellysis?
Wellysis has 27 total employees.
-
What industry is Wellysis in?
Wellysis’s primary industry is Other Healthcare Technology Systems.
-
Is Wellysis a private or public company?
Wellysis is a Private company.
-
What is the current valuation of Wellysis?
The current valuation of Wellysis is .
-
What is Wellysis’s current revenue?
The current revenue for Wellysis is .
-
How much funding has Wellysis raised over time?
Wellysis has raised $26M.
-
Who are Wellysis’s investors?
Kolon Investment, Korea Investment Partners, Kyobo Life Insurance, Kyobo Securities, and Samsung Securities are 5 of 15 investors who have invested in Wellysis.
-
Who are Wellysis’s competitors?
ATsens, Cardioscan (Australia), Biobeat, iRhythm Holdings, and VitalConnect are some of the 7 competitors of Wellysis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
